These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 18830259)

  • 21. Random suppression of T cells that bear specific T cell receptor V beta sequences in adult T cell leukemia/lymphoma (ATLL) patients at each clinical stage: carrier, smoldering, chronic, and acute.
    Ohshima K; Suzumiya J; Kikuchi M; Takeshita M; Tashiro K; Kimura N
    Am J Hematol; 1996 May; 52(1):1-7. PubMed ID: 8638605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction.
    Golden-Mason L; Palmer B; Klarquist J; Mengshol JA; Castelblanco N; Rosen HR
    J Virol; 2007 Sep; 81(17):9249-58. PubMed ID: 17567698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of CADM1/TSLC1/IgSF4 expression in adult T-cell leukemia/lymphoma.
    Nakahata S; Saito Y; Marutsuka K; Hidaka T; Maeda K; Hatakeyama K; Shiraga T; Goto A; Takamatsu N; Asada Y; Utsunomiya A; Okayama A; Kubuki Y; Shimoda K; Ukai Y; Kurosawa G; Morishita K
    Leukemia; 2012 Jun; 26(6):1238-46. PubMed ID: 22289924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced prevalence of serum antibodies against adeno-associated virus type 2 in patients with adult T-cell leukaemia lymphoma.
    Walz CM; Nakamura M; Fukunaga T; Jasiewicz Y; Edler L; Schlehofer JR; Tanaka Y
    J Med Virol; 2001 Sep; 65(1):185-9. PubMed ID: 11505462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small number of HTLV-1-positive cells frequently remains during complete remission after allogeneic hematopoietic stem cell transplantation that are heterogeneous in origin among cases with adult T-cell leukemia/lymphoma.
    Yamasaki R; Miyazaki Y; Moriuchi Y; Tsutsumi C; Fukushima T; Yoshida S; Taguchi J; Inoue Y; Matsuo E; Imaizumi Y; Imanishi D; Fujimoto T; Tsushima H; Honda S; Hata T; Tsukasaki K; Tomonaga M
    Leukemia; 2007 Jun; 21(6):1212-7. PubMed ID: 17410191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B.
    Fisicaro P; Valdatta C; Massari M; Loggi E; Biasini E; Sacchelli L; Cavallo MC; Silini EM; Andreone P; Missale G; Ferrari C
    Gastroenterology; 2010 Feb; 138(2):682-93, 693.e1-4. PubMed ID: 19800335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Epstein-Barr virus-specific immunity in asymptomatic carriers of human T-cell leukemia virus type 1].
    Kwon KW
    Hokkaido Igaku Zasshi; 1995 Mar; 70(2):315-28. PubMed ID: 7774883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New entity, definition and diagnostic criteria of cutaneous adult T-cell leukemia/lymphoma: human T-lymphotropic virus type 1 proviral DNA load can distinguish between cutaneous and smoldering types.
    Amano M; Kurokawa M; Ogata K; Itoh H; Kataoka H; Setoyama M
    J Dermatol; 2008 May; 35(5):270-5. PubMed ID: 18477226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advantage of higher-avidity CTL specific for Tax against human T-lymphotropic virus-1 infected cells and tumors.
    Kitazono T; Okazaki T; Araya N; Yamano Y; Yamada Y; Nakamura T; Tanaka Y; Inoue M; Ozaki S
    Cell Immunol; 2011; 272(1):11-7. PubMed ID: 22030472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer.
    Hamanishi J; Mandai M; Iwasaki M; Okazaki T; Tanaka Y; Yamaguchi K; Higuchi T; Yagi H; Takakura K; Minato N; Honjo T; Fujii S
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3360-5. PubMed ID: 17360651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HTLV-1 Tax-specific memory cytotoxic T lymphocytes in long-term survivors of aggressive-type adult T-cell leukemia/lymphoma.
    Jo T; Noguchi K; Sakai T; Kubota-Koketsu R; Irie S; Matsuo M; Taguchi J; Abe K; Shigematsu K
    Cancer Med; 2022 Sep; 11(17):3238-3250. PubMed ID: 35315593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced tumor-antigen density leads to PD-1/PD-L1-mediated impairment of partially exhausted CD8⁺ T cells.
    Kaiser AD; Schuster K; Gadiot J; Borkner L; Daebritz H; Schmitt C; Andreesen R; Blank C
    Eur J Immunol; 2012 Mar; 42(3):662-71. PubMed ID: 22144176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HTLV-1 and associated adult T-cell leukemia/lymphoma.
    Mahieux R; Gessain A
    Rev Clin Exp Hematol; 2003 Dec; 7(4):336-61. PubMed ID: 15129647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [PD-1 up-regulation influenced apoptosis of HBV-specific CD8 T cells in patients with acute resolved hepatitis B].
    Xu B; Zhang Z; Shi Y; Chen XY; Wang FS
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(17):1158-61. PubMed ID: 19595077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-cell analysis of T-cell receptor repertoire of HTLV-1 Tax-specific cytotoxic T cells in allogeneic transplant recipients with adult T-cell leukemia/lymphoma.
    Tanaka Y; Nakasone H; Yamazaki R; Sato K; Sato M; Terasako K; Kimura S; Okuda S; Kako S; Oshima K; Tanihara A; Nishida J; Yoshikawa T; Nakatsura T; Sugiyama H; Kanda Y
    Cancer Res; 2010 Aug; 70(15):6181-92. PubMed ID: 20647322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus in adult T-cell leukemia/lymphoma.
    Tokunaga M; Imai S; Uemura Y; Tokudome T; Osato T; Sato E
    Am J Pathol; 1993 Nov; 143(5):1263-9. PubMed ID: 8238243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-HTLV-1 antibody positive cutaneous T-cell lymphoma.
    Kikuchi A; Ohata Y; Matsumoto H; Sugiura M; Nishikawa T
    Cancer; 1997 Jan; 79(2):269-74. PubMed ID: 9010100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients.
    Peng G; Li S; Wu W; Tan X; Chen Y; Chen Z
    Mol Immunol; 2008 Feb; 45(4):963-70. PubMed ID: 17868872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
    Raziorrouh B; Ulsenheimer A; Schraut W; Heeg M; Kurktschiev P; Zachoval R; Jung MC; Thimme R; Neumann-Haefelin C; Horster S; Wächtler M; Spannagl M; Haas J; Diepolder HM; Grüner NH
    Gastroenterology; 2011 Oct; 141(4):1422-31, 1431.e1-6. PubMed ID: 21763239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.